GlassScriptPhysician profile
Kathleen E Horne
NPI 1295774024
$6,622.39
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,178 · 2020: $2,024 · 2021: $2,421.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $689.16 | 2019-2021 | |
| Amgen INC. | $683.16 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $639.29 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $618.56 | 2019-2021 | |
| Glaxosmithkline, LLC. | $568.28 | 2019-2021 | |
| Pfizer INC. | $559.42 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $557.44 | 2019-2021 | |
| Lilly USA, LLC | $376.28 | 2019-2021 | |
| Amarin Pharma, INC. | $329.91 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $311.96 | 2019-2021 | |
| Abbvie INC. | $241.99 | 2021 | |
| Sanofi-Aventis U.S. LLC | $227.40 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $101.69 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.35 | 2019-2021 | |
| Astellas Pharma US INC | $63.51 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $58.07 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $57.80 | 2021 | |
| Sunovion Pharmaceuticals INC. | $47.53 | 2021 | |
| Eisai INC. | $43.27 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $41.32 | 2021 | |
| Sanofi Pasteur INC. | $40.77 | 2020-2021 | |
| Allergan, INC. | $39.85 | 2019-2020 | |
| Esperion Therapeutics, INC. | $39.31 | 2021 | |
| Philips North America LLC | $32.98 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $27.62 | 2020-2021 | |
| Shire North American Group INC | $23.14 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.99 | 2021 | |
| Dexcom, INC. | $17.04 | 2021 | |
| Circassia INC. | $16.98 | 2019 | |
| Abbott Laboratories | $16.14 | 2021 | |
| Medtronic, INC. | $15.89 | 2021 | |
| Zealand Pharma US, INC. | $15.15 | 2021 | |
| Ironshore Pharmaceuticals INC. | $12.75 | 2019 | |
| Supernus Pharmaceuticals, INC. | $12.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Horne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.